Council News Vol. 7, no. 2

i[:] try-supported clinical trials in this key scientific area. To make the award process as timely as possible, reviewers will use NIAID's electronic initial review system to review applications and enter critiques and scores into a secure Web server. At about the seventh week of the process, SRG members will gain access to each other's reviews and view each other's comments online. Then, the application will be discussed and voted on during a monthly conference call. Within the next two weeks, summary statements will be ready, and all other administrative requirements will be completed during weeks 10 to 13. At that point, applicants in the fundable range will send NIH all necessary materials, expedited Council review will take place, and the Institute will make the awards. You can find the RFA on the Web at http://www.nih.gov/ grants/guide/rfa-files/RFAAI-98-006.html. Wide NIH interest With its electronic review systems in place, NIAID is already beginning to recruit SRG members. Institutes that do not have expedited Council review are developing procedures to do so. The initiative is being cosponsored by the National Heart, Lung, and Blood Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; and the NIH Office of Research on Women's Health. NIAID's Electronic Initial Review System NIH-Wide NIDR NIAID NIGMS NIDCD 53 Events 24 Events 2 Events 5 Events 5 Events 7 Events NCI CSR/TMP NIAID expects to To C finish testing the electronic review AID site, train review- Hyp( ers, assist basic (CS researcher- NIN industry collaborations, and work with applicants by September; the first applications are scheduled to arrive in October for awards in January 1999. This fall, CSR's AIDS study sections will be using the basic ome: S Study Sections in CSR eraccelerated Review R, NIAID, NIAMS, NIDDK, IDS, NHLBI, and ORWH) features of the TMP electronic peer review trial. We will provide more information on that effort in the September issue of this newsletter. Hyperaccelerated Review RFA-Key Features Application page limit-10 pages plus references for the science portion. IRB approval of mechanistic studies and core trial -required for award but not application. Agreement of PI and sponsor of core clinical trial -required of applicant and institution. Support levels-Limited to $160,000 per year for direct costs except by permission. Types of projects-Both pilot or feasibility and definitive projects will be eligible. Amended applications-By invitation only (limited to those with minor problems; will be reviewed and voted on at next monthly conference call).

/ 20

Actions

file_download Download Options Download this page PDF - Pages 1-20 Image - Page 18 Plain Text - Page 18

About this Item

Title
Council News Vol. 7, no. 2
Author
National Institute of Allergy and Infectious Diseases (U.S.)
Canvas
Page 18
Publication
National Institute of Allergy and Infectious Diseases (U.S.)
1998-06
Subject terms
newsletters
Item type:
newsletters

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0492.014
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0492.014/18

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0492.014

Cite this Item

Full citation
"Council News Vol. 7, no. 2." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0492.014. University of Michigan Library Digital Collections. Accessed June 7, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.